GLP-1 Receptor Agonist Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type

May 2025 | 73 pages | ID: GE37E0900CA1EN
Prof Research

Abstracts

GLP-1 Receptor Agonist Market Summary

Introduction and Market Overview

GLP-1 receptor agonists (GLP-1 RAs), including Ozempic, Trulicity, and Wegovy, manage type 2 diabetes (T2DM, 537 million cases globally) and obesity (424 million adults), with projections of 643 million T2DM cases by 2030. The market is driven by their dual efficacy in glycemic control and weight loss, reducing cardiovascular risks by 15-20%, and high adherence (20% better with weekly injections). Expanded indications, like Wegovy for cardiovascular disease, and novel oral formulations (e.g., Rybelsus) fuel growth. The global GLP-1 RA market is estimated at USD 40-70 billion in 2025, with a CAGR of 13%-18% through 2030.

Regional Market Trends

• North America: The U.S. leads with high T2DM and obesity rates, while Canada emphasizes preventive care.
• Europe: Germany, France, and the UK drive growth with robust diabetes management.
• Asia Pacific: China and India see rising demand due to lifestyle changes, with Japan focusing on oral formulations.
• Rest of the World: Brazil expands diabetes care, while the Middle East addresses metabolic disorders.

Distribution Channel Analysis

• Hospital Pharmacies: Expected growth of 13.5%-18.5%, driven by T2DM prescriptions. Trends focus on specialized care.
• Retail Pharmacies: Projected growth of 13.0%-18.0%, linked to obesity management. Advances emphasize accessibility.
• Online Pharmacies: Anticipated growth of 14.0%-19.0%, for patient convenience. Trends highlight digital access.

Type Analysis

• Ozempic: Expected growth of 14.0%-19.0%, valued for glycemic control. Trends focus on cardiovascular benefits.
• Trulicity: Projected growth of 13.5%-18.5%, suited for weekly dosing. Advances emphasize adherence.
• Mounjaro: Anticipated growth of 15.0%-20.0%, for dual GIP/GLP-1 action. Trends highlight weight loss efficacy.
• Wegovy: Expected growth of 14.5%-19.5%, for obesity. Developments prioritize expanded indications.
• Rybelsus: Expected growth of 15.5%-20.5%, as an oral option. Trends focus on patient preference.
• Saxenda: Expected growth of 12.5%-17.5%, for weight management. Trends highlight pediatric use.
• Victoza: Expected growth of 12.0%-17.0%, for T2DM. Developments prioritize combination therapies.
• Zepbound: Expected growth of 14.0%-19.0%, for obesity. Trends focus on high efficacy.
• Other Products: Expected growth of 12.0%-17.0%, covering novel agents. Developments prioritize oral innovations.

Key Market Players

• Novo Nordisk: Offers Ozempic and Wegovy for T2DM and obesity.
• Eli Lilly: Develops Mounjaro and Trulicity.
• Sanofi: Focuses on diabetes therapies.
• AstraZeneca: Provides supportive metabolic treatments.

Porter’s Five Forces Analysis

• Threat of New Entrants: Low, due to high R&D costs and patent protections.
• Threat of Substitutes: Moderate, with other diabetes drugs competing, but GLP-1 RAs excel in dual efficacy.
• Bargaining Power of Buyers: Moderate, with insurers negotiating prices, but high demand limits leverage.
• Bargaining Power of Suppliers: Low, with multiple API providers.
• Competitive Rivalry: High, with players competing on efficacy and delivery.

Market Opportunities and Challenges

Opportunities:

• Addressing T2DM, affecting 537 million people.
• Managing obesity, impacting 424 million adults.
• Leveraging cardiovascular benefits, reducing risks by 15-20%.
• Utilizing oral formulations, improving adherence by 20%.
• Supporting COVID-19 patients with high T2DM risks.
• Expanding indications like cardiovascular disease.

Challenges:

• High costs of GLP-1 RAs limiting access.
• Regulatory delays for new formulations.
• Competition from other diabetes therapies.
• Supply chain constraints for high-demand drugs.
• Patient adherence issues in low-income regions.

Contents

CHAPTER 1 EXECUTIVE SUMMARY

CHAPTER 2 ABBREVIATION AND ACRONYMS

CHAPTER 3 PREFACE

3.1 Research Scope
3.2 Research Sources
  3.2.1 Data Sources
  3.2.2 Assumptions
3.3 Research Method
Chapter Four Market Landscape
4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users

CHAPTER 5 MARKET TREND ANALYSIS

5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats

CHAPTER 6 INDUSTRY CHAIN ANALYSIS

6.1 Upstream/Suppliers Analysis
6.2 Glp-1 Receptor Agonist Analysis
  6.2.1 Technology Analysis
  6.2.2 Cost Analysis
  6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users

CHAPTER 7 LATEST MARKET DYNAMICS

7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics

CHAPTER 8 HISTORICAL AND FORECAST GLP-1 RECEPTOR AGONIST MARKET IN NORTH AMERICA (2020-2030)

8.1 Glp-1 Receptor Agonist Market Size
8.2 Glp-1 Receptor Agonist Market by End Use
8.3 Competition by Players/Suppliers
8.4 Glp-1 Receptor Agonist Market Size by Type
8.5 Key Countries Analysis
  8.5.1 United States
  8.5.2 Canada
  8.5.3 Mexico

CHAPTER 9 HISTORICAL AND FORECAST GLP-1 RECEPTOR AGONIST MARKET IN SOUTH AMERICA (2020-2030)

9.1 Glp-1 Receptor Agonist Market Size
9.2 Glp-1 Receptor Agonist Market by End Use
9.3 Competition by Players/Suppliers
9.4 Glp-1 Receptor Agonist Market Size by Type
9.5 Key Countries Analysis
  9.5.1 Brazil
  9.5.2 Argentina
  9.5.3 Chile
  9.5.4 Peru

CHAPTER 10 HISTORICAL AND FORECAST GLP-1 RECEPTOR AGONIST MARKET IN ASIA & PACIFIC (2020-2030)

10.1 Glp-1 Receptor Agonist Market Size
10.2 Glp-1 Receptor Agonist Market by End Use
10.3 Competition by Players/Suppliers
10.4 Glp-1 Receptor Agonist Market Size by Type
10.5 Key Countries Analysis
  10.5.1 China
  10.5.2 India
  10.5.3 Japan
  10.5.4 South Korea
  10.5.5 Southest Asia
  10.5.6 Australia

CHAPTER 11 HISTORICAL AND FORECAST GLP-1 RECEPTOR AGONIST MARKET IN EUROPE (2020-2030)

11.1 Glp-1 Receptor Agonist Market Size
11.2 Glp-1 Receptor Agonist Market by End Use
11.3 Competition by Players/Suppliers
11.4 Glp-1 Receptor Agonist Market Size by Type
11.5 Key Countries Analysis
  11.5.1 Germany
  11.5.2 France
  11.5.3 United Kingdom
  11.5.4 Italy
  11.5.5 Spain
  11.5.6 Belgium
  11.5.7 Netherlands
  11.5.8 Austria
  11.5.9 Poland
  11.5.10 Russia

CHAPTER 12 HISTORICAL AND FORECAST GLP-1 RECEPTOR AGONIST MARKET IN MEA (2020-2030)

12.1 Glp-1 Receptor Agonist Market Size
12.2 Glp-1 Receptor Agonist Market by End Use
12.3 Competition by Players/Suppliers
12.4 Glp-1 Receptor Agonist Market Size by Type
12.5 Key Countries Analysis
  12.5.1 Egypt
  12.5.2 Israel
  12.5.3 South Africa
  12.5.4 Gulf Cooperation Council Countries
  12.5.5 Turkey

CHAPTER 13 SUMMARY FOR GLOBAL GLP-1 RECEPTOR AGONIST MARKET (2020-2025)

13.1 Glp-1 Receptor Agonist Market Size
13.2 Glp-1 Receptor Agonist Market by End Use
13.3 Competition by Players/Suppliers
13.4 Glp-1 Receptor Agonist Market Size by Type

CHAPTER 14 GLOBAL GLP-1 RECEPTOR AGONIST MARKET FORECAST (2025-2030)

14.1 Glp-1 Receptor Agonist Market Size Forecast
14.2 Glp-1 Receptor Agonist Application Forecast
14.3 Competition by Players/Suppliers
14.4 Glp-1 Receptor Agonist Type Forecast

CHAPTER 15 ANALYSIS OF GLOBAL KEY VENDORS

15.1 Nordisk
  15.1.1 Company Profile
  15.1.2 Main Business and GLP-1 Receptor Agonist Information
  15.1.3 SWOT Analysis of Nordisk
  15.1.4 Nordisk GLP-1 Receptor Agonist Revenue, Gross Margin and Market Share (2020-2025)
15.2 Eli Lilly
  15.2.1 Company Profile
  15.2.2 Main Business and GLP-1 Receptor Agonist Information
  15.2.3 SWOT Analysis of Eli Lilly
  15.2.4 Eli Lilly GLP-1 Receptor Agonist Revenue, Gross Margin and Market Share (2020-2025)
Please ask for sample pages for full companies list
Tables and Figures
Table Abbreviation and Acronyms
Table Research Scope of Glp-1 Receptor Agonist Report
Table Data Sources of Glp-1 Receptor Agonist Report
Table Major Assumptions of Glp-1 Receptor Agonist Report
Figure Market Size Estimated Method
Figure Major Forecasting Factors
Figure Glp-1 Receptor Agonist Picture
Table Glp-1 Receptor Agonist Classification
Table Glp-1 Receptor Agonist Applications
Table Drivers of Glp-1 Receptor Agonist Market
Table Restraints of Glp-1 Receptor Agonist Market
Table Opportunities of Glp-1 Receptor Agonist Market
Table Threats of Glp-1 Receptor Agonist Market
Table Covid-19 Impact For Glp-1 Receptor Agonist Market
Table Raw Materials Suppliers
Table Different Production Methods of Glp-1 Receptor Agonist
Table Cost Structure Analysis of Glp-1 Receptor Agonist
Table Key End Users
Table Latest News of Glp-1 Receptor Agonist Market
Table Merger and Acquisition
Table Planned/Future Project of Glp-1 Receptor Agonist Market
Table Policy of Glp-1 Receptor Agonist Market
Table 2020-2030 North America Glp-1 Receptor Agonist Market Size
Figure 2020-2030 North America Glp-1 Receptor Agonist Market Size and CAGR
Table 2020-2030 North America Glp-1 Receptor Agonist Market Size by Application
Table 2020-2025 North America Glp-1 Receptor Agonist Key Players Revenue
Table 2020-2025 North America Glp-1 Receptor Agonist Key Players Market Share
Table 2020-2030 North America Glp-1 Receptor Agonist Market Size by Type
Table 2020-2030 United States Glp-1 Receptor Agonist Market Size
Table 2020-2030 Canada Glp-1 Receptor Agonist Market Size
Table 2020-2030 Mexico Glp-1 Receptor Agonist Market Size
Table 2020-2030 South America Glp-1 Receptor Agonist Market Size
Figure 2020-2030 South America Glp-1 Receptor Agonist Market Size and CAGR
Table 2020-2030 South America Glp-1 Receptor Agonist Market Size by Application
Table 2020-2025 South America Glp-1 Receptor Agonist Key Players Revenue
Table 2020-2025 South America Glp-1 Receptor Agonist Key Players Market Share
Table 2020-2030 South America Glp-1 Receptor Agonist Market Size by Type
Table 2020-2030 Brazil Glp-1 Receptor Agonist Market Size
Table 2020-2030 Argentina Glp-1 Receptor Agonist Market Size
Table 2020-2030 Chile Glp-1 Receptor Agonist Market Size
Table 2020-2030 Peru Glp-1 Receptor Agonist Market Size
Table 2020-2030 Asia & Pacific Glp-1 Receptor Agonist Market Size
Figure 2020-2030 Asia & Pacific Glp-1 Receptor Agonist Market Size and CAGR
Table 2020-2030 Asia & Pacific Glp-1 Receptor Agonist Market Size by Application
Table 2020-2025 Asia & Pacific Glp-1 Receptor Agonist Key Players Revenue
Table 2020-2025 Asia & Pacific Glp-1 Receptor Agonist Key Players Market Share
Table 2020-2030 Asia & Pacific Glp-1 Receptor Agonist Market Size by Type
Table 2020-2030 China Glp-1 Receptor Agonist Market Size
Table 2020-2030 India Glp-1 Receptor Agonist Market Size
Table 2020-2030 Japan Glp-1 Receptor Agonist Market Size
Table 2020-2030 South Korea Glp-1 Receptor Agonist Market Size
Table 2020-2030 Southeast Asia Glp-1 Receptor Agonist Market Size
Table 2020-2030 Australia Glp-1 Receptor Agonist Market Size
Table 2020-2030 Europe Glp-1 Receptor Agonist Market Size
Figure 2020-2030 Europe Glp-1 Receptor Agonist Market Size and CAGR
Table 2020-2030 Europe Glp-1 Receptor Agonist Market Size by Application
Table 2020-2025 Europe Glp-1 Receptor Agonist Key Players Revenue
Table 2020-2025 Europe Glp-1 Receptor Agonist Key Players Market Share
Table 2020-2030 Europe Glp-1 Receptor Agonist Market Size by Type
Table 2020-2030 Germany Glp-1 Receptor Agonist Market Size
Table 2020-2030 France Glp-1 Receptor Agonist Market Size
Table 2020-2030 United Kingdom Glp-1 Receptor Agonist Market Size
Table 2020-2030 Italy Glp-1 Receptor Agonist Market Size
Table 2020-2030 Spain Glp-1 Receptor Agonist Market Size
Table 2020-2030 Belgium Glp-1 Receptor Agonist Market Size
Table 2020-2030 Netherlands Glp-1 Receptor Agonist Market Size
Table 2020-2030 Austria Glp-1 Receptor Agonist Market Size
Table 2020-2030 Poland Glp-1 Receptor Agonist Market Size
Table 2020-2030 Russia Glp-1 Receptor Agonist Market Size
Table 2020-2030 MEA Glp-1 Receptor Agonist Market Size
Figure 2020-2030 MEA Glp-1 Receptor Agonist Market Size and CAGR
Table 2020-2030 MEA Glp-1 Receptor Agonist Market Size by Application
Table 2020-2025 MEA Glp-1 Receptor Agonist Key Players Revenue
Table 2020-2025 MEA Glp-1 Receptor Agonist Key Players Market Share
Table 2020-2030 MEA Glp-1 Receptor Agonist Market Size by Type
Table 2020-2030 Egypt Glp-1 Receptor Agonist Market Size
Table 2020-2030 Israel Glp-1 Receptor Agonist Market Size
Table 2020-2030 South Africa Glp-1 Receptor Agonist Market Size
Table 2020-2030 Gulf Cooperation Council Countries Glp-1 Receptor Agonist Market Size
Table 2020-2030 Turkey Glp-1 Receptor Agonist Market Size
Table 2020-2025 Global Glp-1 Receptor Agonist Market Size by Region
Table 2020-2025 Global Glp-1 Receptor Agonist Market Size Share by Region
Table 2020-2025 Global Glp-1 Receptor Agonist Market Size by Application
Table 2020-2025 Global Glp-1 Receptor Agonist Market Share by Application
Table 2020-2025 Global Glp-1 Receptor Agonist Key Vendors Revenue
Figure 2020-2025 Global Glp-1 Receptor Agonist Market Size and Growth Rate
Table 2020-2025 Global Glp-1 Receptor Agonist Key Vendors Market Share
Table 2020-2025 Global Glp-1 Receptor Agonist Market Size by Type
Table 2020-2025 Global Glp-1 Receptor Agonist Market Share by Type
Table 2025-2030 Global Glp-1 Receptor Agonist Market Size by Region
Table 2025-2030 Global Glp-1 Receptor Agonist Market Size Share by Region
Table 2025-2030 Global Glp-1 Receptor Agonist Market Size by Application
Table 2025-2030 Global Glp-1 Receptor Agonist Market Share by Application
Table 2025-2030 Global Glp-1 Receptor Agonist Key Vendors Revenue
Figure 2025-2030 Global Glp-1 Receptor Agonist Market Size and Growth Rate
Table 2025-2030 Global Glp-1 Receptor Agonist Key Vendors Market Share
Table 2025-2030 Global Glp-1 Receptor Agonist Market Size by Type
Table 2025-2030 Glp-1 Receptor Agonist Global Market Share by Type